Cholinergic inositol phosphate formation in striatal neurons is mediated by distinct mechanisms.
In murine striatal neurons devoid of functional synapses (6 days in vitro) the cholinergic agonists carbachol and arecoline evoked dose-dependent inositol phosphate (InsP) responses with mean log EC50s of -4.1 +/- 0.5 and -4.48 +/- 0.1, respectively. Carbachol (1 mM) and arecoline (1 mM) responses were insensitive to tetrodotoxin, a voltage-sensitive Na+ channel blocker, and were blocked by pirenzepine with relatively low affinity (logIC50 = -5.9 +/- 0.3 for the carbachol response and logIC50 = -5.8 +/- 0.3 for the arecoline response). After synaptogenesis (13 days in vitro) the maximal carbachol effect doubled whereas the arecoline response remained unchanged. This additional effect was sensitive to tetrodotoxin and the voltage-dependent Ca2+ channel blocker, omega-conotoxin. The tetrodotoxin-sensitive carbachol response was blocked by lower concentrations of pirenzepine than the tetrodotoxin-insensitive carbachol response. More than 75% of the InsP response evoked by low concentrations of muscarine (1 and 10 microM) was sensitive to tetrodotoxin whereas only 38% of the InsP response stimulated by 1 mM of muscarine could be blocked by tetrodotoxin. These results suggest that there are at least two different mechanisms (depending on the stage of development), activated most probably by two different muscarinic receptors responsible for the carbachol-induced InsP formation in striatal neurons.
Schmidt
B H
BH
Centre CNRS-INSERM de Pharmacologie-Endocrinologie, Montpellier, France.
Manzoni
O J
OJ
Royer
M
M
Bockaert
J
J
Sladeczek
F A
FA
D000818:Animals; D001115:Arecoline / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002217:Carbachol / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism*; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000096:biosynthesis*; D051379:Mice; D009116:Muscarine / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000145:classification / Q000187:drug effects / Q000378:metabolism*; D013779:Tetrodotoxin / Q000494:pharmacology
D007295:Inositol Phosphates; D011976:Receptors, Muscarinic; D013779:Tetrodotoxin; D001115:Arecoline; D009116:Muscarine; D002217:Carbachol; D002118:Calcium